Editorial Team
EDITOR-IN-CHIEF
- Jean François Rossi, Jean-François Rossi is Professor of Hematology since 1993. He previously was medical oncologist in the Cancer Center of Montpellier from 1987 and became head of the Hematology Department from 1994 to 2012 at the University Hospital of Montpellier, France. He is now consultant at the University Hospital of Montpellier and at the University Hospital of Nîmes, and was associate professor at Suzhou University (China). Professor Rossi obtained his medical degree and his PhD from the University of Montpellier. He also untertook post-doctoral work at the Cancer Center in Tucson (BGM Durie), at the VUMC San Antonio (GR Mundy) and at the NCI (SA Rosenberg). Professor Rossi was certificated in Rhumatology, Immunology, Medical Oncology, and Hematology. He developed translational research (INSERM U1040, Instiitute of Biotherapy, professor Bernard Klein), particularly targeted therapy, immune therapy for B-cell malignancies, including anti-interleukin 6, anti-BAFF-APRIL anti-HB-EGF therapy, anti-CD20 modulation, cellular therapy, i.e., dendritic cells, T and activated/amplified NK cells from umbilical cord blood with new technology, and identifying active subpopulations (Martin Villalba, INSERM and EEC network CliNK). Professor Rossi is implicated in different scientific advisory boards from innovative start-up companies (BETAINNOV, ORIBASE PHARMA and URODELIA). With BETAINNOV, he participates to new immune functions through the MHC I complex in both dysimmune diseases and hematological malignancies.
Professor Rossi is member of the American Society of Hematology, American Society of Clinical Oncology, European Bone Marrow Transplantation and was member of the American Society of Bone and Mineral Research. He is member of the Castleman Disease Collaborative Network (CDCN) scientific advisory board.
Professor Rossi has published more than 189 peer-viewed articles in the field of immune therapy, identification of new biological targets in cancer, particularly in B-cell malignancies, in different hematology, immunology and cancer journals. He also serves as reviewer for different jounals in this field of research., France
- Xiaochuan Yang, Dr. Xiaochuan Yang is a physician scientist with special interest in hematology/oncology research. With a B.S. in Pharmaceutical Sciences from Peking University (2004) and a PhD in Medicinal Chemistry from Georgia State University (2010), both of his thesis topics were focused on small molecular anti-cancer drug development. The evolving curiosity from chemistry innovation to application led him to pursue clinical pharmacology research at Kimmel Cancer Center at Johns Hopkins later. The 3 years postdoctoral research at Hopkins involved detailed studies of Flt3-mutated AML, its targeted and combination therapy, and its potential resistance mechanism against therapy. His work was presented at the 53rd ASH meeting, and resulted in several pulications on journals including Blood, Oncogene, and British Journal of Haematology. In 2013, Dr. Yang was awarded the Rangos Award for Creativity in Cancer Discovery at Johns Hopkins University. Later, Dr. Yang went to Ben Gurion Univeristy of the Negev in Israel for study in medicine and obtained his MD there in 2017. During his medical school, Dr. Yang has actively rotated in the services of Surgical Oncology in Memorial Sloan Kettering Cancer Center and Hematology in NIH Clinical Center. Right now, Dr. Yang is a resident in Internal Medicine at Mount Sinai St Luke’s- Mount Sinai West Hospital Center, and continuing his journey in the frontier of hematology/oncology research., United States
HONORARY EDITOR-IN-CHIEF
- Shimon Slavin, The International Center for Cell Therapy & Cancer Immunotherapy (CTCI), Israel
- Sheng-Fung Lin, Kaohsiung Medical University Hospital, Taiwan, Province of China
- Yusuke Furukawa, Professor of Medicine
Division of Stem Cell Regulation
Jichi Medical University, Japan
EDITORIAL BOARD MEMBERS
- Mudi Misgav, The Tel-Aviv University Sackler School of Medicine, Israel
- Imen MOUMNI, Laboratory of Molecular and Cellular Hematology, Pasteur Institute of Tunis,, Tunisia
- Saeed Shoar, Tehran University of Medical Sciences, Iran, Islamic Republic Of
- Ya-Wei Qiang, University of Arkansas for Medical Sciences Myeloma Institute, United States
- Shiva Razi, Orthopedic Research Center, Mashhad University of Medical Sciences, Iran, Islamic Republic Of
- ANDY PETROIANU, School of Medicine, Federal University of Minas Gerais, Brazil
- Ahmad Farrag Thabet, Ass.prof. of internal medicine and clinical hematology, Assiut university, Egypt
- PRITI ELHENCE, Sanjay Gandhi Postgraduate Institute of Medical Sciences, India
- Mang Xiao, Radiation Countermeasures Program, Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, United States
- Kaoru Okazaki, National Hospital Organization Shikoku Medical Center for Children and Adults, Japan
- Kuan-Tsou Lin, Kaohsiung Blood Center, Taiwan Blood Services Foundation, Taiwan, Province of China
- Irina Anatol’evna Pashkova, The head of blood transfusion department in Krasnodar regional hospital, the head of Krasnodar regional center of transplantology in Krasnodar regional hospital, Russian Federation
- Kwok Ming Ho, Royal Perth Hospital and University of Western Australia, Australia
- Lu Cai, University of Louisville, United States
- Shen Meng Gao, The first affiliated hospital of Wenzhou medical university, China
- Yubin Ge, Wayne State University School of Medicine, United States
- Kwabena Nsiah, Kwame Nkrumah University of Science and Technology, Ghana
- Souvenir D Tachado, Beth Israel Deaconess Medical Center/ Harvard Medical School, United States
- ASHER WINDER, Wolfson Medical Center, Tel-Aviv University,, Israel
- Mingqiang Ren, Cancer Center of Georgia Regents University, United States
- Ali Aycicek, Istanbul Kanuni Sultan Süleyman Education and Research Hospital, Turkey
- Farhad Zaker, Iran university medical sciences, Iran, Islamic Republic Of
- Tarun Kumar Dutta, Jawaharlal Institute Of Postgraduate Medical Education And Research, India
- Paolo Prandoni, Clinica Medica 2 and Thromboembolism Unit, Chie, University of Padova, Italy
- Fakher Rahim, Ahvaz Jundishapur University of Medical Sciences, Iran, Islamic Republic Of
- Youchun Wang, National Institutes for Food and Drug Control (NIFDC), China
- Jian Pan, Children's Hospital of Soochow University, Suzhou, China
- Lukas Smolej, University Hospital and Charles University in Prague, Czech Republic
- Cihan Ay, Medical University of Vienna, Austria
- Yong Zhao, Institute of Zoology, Chinese Academy of Sciences, China
- XIAOHONG CAI, Medical School of Shanghai Jiao Tong University, China
- Hale Aral, Ministry of Health Istanbul Research and Education Hospital, Turkey
- Yunping Luo, Chinese Academy of Medical Science & Peking Union Medical College, China
- Nasim Valizadeh, Tehran University of Medical Sciences, Iran, Islamic Republic Of
- Yeling Lu, Medical College of Shanghai JiaoTong University, China
- Zhinan Yin, International Immunology Center, Jinan University, China
- WEI ZHANG, East China Normal University, China
- Jonathan R Keller, National Cancer Institute, National Institutes of Health, United States
- Jean François Rossi, Jean-François Rossi is Professor of Hematology since 1993. He previously was medical oncologist in the Cancer Center of Montpellier from 1987 and became head of the Hematology Department from 1994 to 2012 at the University Hospital of Montpellier, France. He is now consultant at the University Hospital of Montpellier and at the University Hospital of Nîmes, and was associate professor at Suzhou University (China). Professor Rossi obtained his medical degree and his PhD from the University of Montpellier. He also untertook post-doctoral work at the Cancer Center in Tucson (BGM Durie), at the VUMC San Antonio (GR Mundy) and at the NCI (SA Rosenberg). Professor Rossi was certificated in Rhumatology, Immunology, Medical Oncology, and Hematology. He developed translational research (INSERM U1040, Instiitute of Biotherapy, professor Bernard Klein), particularly targeted therapy, immune therapy for B-cell malignancies, including anti-interleukin 6, anti-BAFF-APRIL anti-HB-EGF therapy, anti-CD20 modulation, cellular therapy, i.e., dendritic cells, T and activated/amplified NK cells from umbilical cord blood with new technology, and identifying active subpopulations (Martin Villalba, INSERM and EEC network CliNK). Professor Rossi is implicated in different scientific advisory boards from innovative start-up companies (BETAINNOV, ORIBASE PHARMA and URODELIA). With BETAINNOV, he participates to new immune functions through the MHC I complex in both dysimmune diseases and hematological malignancies.
Professor Rossi is member of the American Society of Hematology, American Society of Clinical Oncology, European Bone Marrow Transplantation and was member of the American Society of Bone and Mineral Research. He is member of the Castleman Disease Collaborative Network (CDCN) scientific advisory board.
Professor Rossi has published more than 189 peer-viewed articles in the field of immune therapy, identification of new biological targets in cancer, particularly in B-cell malignancies, in different hematology, immunology and cancer journals. He also serves as reviewer for different jounals in this field of research., France
- Ibrahim AYDIN, GATA School of Medicine Department of Biochemistry, Turkey
- Alexandre Arcaro, Inselspital, Bern University Hospital, Switzerland, Switzerland
- Ernesto De Meis, Universidade Federal do Rio de Janeiro and Instituto Nacional de Câncer Rio de Janeiro, Brazil
- Ingo Ahrens, Heart Centre, University of Freiburg, Germany
- Emad Shash, National Cancer Institute, Cairo University, Egypt
- Catherine Lai, National Institutes of Health,
National Cancer Institute, United States
- Wenbin Qian, College of Medicine, Zhejiang University, China
- Enqi Liu, Xi’an Jiaotong University Cardiovascular Research Center, China
- Mohammad Najafi, Iran University of Medical Sciences, Iran, Islamic Republic Of
- Shaker A Mousa, Executive VP and Chairman
Vice Provost, Albany College of Pharmacy and Health Sciences
The Pharmaceutical Research Institute, United States
- Gangjian Qin, Northwestern University Feinberg School of Medicine, United States
- Dayong Gao, University of Washington, Seattle, United States
- Cezary W Watala, Chair of Biomedical Sciences,
Medical University of Lodz, Poland
- Fevzi Altuntas, Yıldırım Beyazıt University, Ankara Oncology Hospital, Turkey
- Yin Xia, The Chinese University of Hong Kong, Hong Kong
- Yan Shi, Shandong University, China
- Evan Ingley, Harry Perkins Institute of Medical Research, The University of Western Australia, Australia
- Akshat Jain, Hofstra NorthShore LIJ School of Medicine, United States
- Marian L Kruzel, University of Texas Health Science Center at Houston, United States
- Adriana Georgescu, Institute of Cellular Biology and Pathology 'Nicolae Simionescu', Romania
- Jiong Hu, Shanghai JiaoTong University, China
- Eugene S Kim, University of Southern California, Keck School of Medicine, United States
- Jianhua Yu, The Ohio State University, United States
- Javad Zavar Reza, Shahid Sadoughi University of Medical Sciences and Health Services, Iran, Islamic Republic Of
- Huaizhu Wu, Baylor College of Medicine, United States
- Yusuke Shiozawa, Comprehensive Cancer Center, Wake Forest School of Medicine, United States
- Hua Su, University of California, San Francisco, United States
- Soon Thye Lim, Head and Senior Consultant
Division of Medical Oncology
National Cancer Centre Singapore, Singapore
- James CS CHIM, Queen Mary Hospital
The University of Hong Kong, Hong Kong
- RAJENDRA CHAUDHARY, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI), India
- Mohammad Hamid, Biotechnology Research Center, Pasteur Institute of Iran, Iran, Islamic Republic Of
- Chanchal Rana, Chief of laboratory
Dr Lal Path Labs, Lucknow UP, India, India
- Carlos Solano, Head Hematology
Hematology and Medical Oncology Department
Hospital Clinico Universitario, Spain
- Sebastian Grosicki, Head of Department of Hematology, Municipal Hospital in Chorzow, Poland
- Jamie Case, Indiana University School of Medicine,, United States
- Yongxin Ru, Institute of Hematology & Blood Diseases Hospital, Peking Union Medical College, China
- Sheng-Fung Lin, Kaohsiung Medical University Hospital, Taiwan, Province of China
- Beata Olas, Faculty of Biology and Environmental Protection, University of Lodz, Poland
- Wang Rui Tao, the Second Affiliated Hospital, Harbin Medical University, China
 |
|
|
